55 related articles for article (PubMed ID: 9442393)
1. Identification of target genes of the lymphoid-specific transcription factor Oct2.
Pfisterer P; Hess J; Wirth T
Immunobiology; 1997 Dec; 198(1-3):217-26. PubMed ID: 9442393
[TBL] [Abstract][Full Text] [Related]
2. CRISP-3, a protein with homology to plant defense proteins, is expressed in mouse B cells under the control of Oct2.
Pfisterer P; König H; Hess J; Lipowsky G; Haendler B; Schleuning WD; Wirth T
Mol Cell Biol; 1996 Nov; 16(11):6160-8. PubMed ID: 8887646
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Oct2 from the channel catfish: functional preference for a variant octamer motif.
Ross DA; Magor BG; Middleton DL; Wilson MR; Miller NW; Clem LW; Warr GW
J Immunol; 1998 Apr; 160(8):3874-82. PubMed ID: 9558093
[TBL] [Abstract][Full Text] [Related]
4. Molecular principles of Oct2-mediated gene activation in B cells.
Wirth T; Pfisterer P; Annweiler A; Zwilling S; König H
Immunobiology; 1995 Jul; 193(2-4):161-70. PubMed ID: 8530140
[TBL] [Abstract][Full Text] [Related]
5. Identification of CD36 as the first gene dependent on the B-cell differentiation factor Oct-2.
König H; Pfisterer P; Corcoran LM; Wirth T
Genes Dev; 1995 Jul; 9(13):1598-607. PubMed ID: 7543064
[TBL] [Abstract][Full Text] [Related]
6. Lymphoid- and myeloid-specific activity of the PU.1 promoter is determined by the combinatorial action of octamer and ets transcription factors.
Kistler B; Pfisterer P; Wirth T
Oncogene; 1995 Sep; 11(6):1095-106. PubMed ID: 7566969
[TBL] [Abstract][Full Text] [Related]
7. Differential transactivation potential of Oct1 and Oct2 is determined by additional B cell-specific activities.
Pfisterer P; Annweiler A; Ullmer C; Corcoran LM; Wirth T
EMBO J; 1994 Apr; 13(7):1654-63. PubMed ID: 8157005
[TBL] [Abstract][Full Text] [Related]
8. Lymphoid-specific transcription mediated by the conserved octamer site: who is doing what?
Matthias P
Semin Immunol; 1998 Apr; 10(2):155-63. PubMed ID: 9618761
[TBL] [Abstract][Full Text] [Related]
9. Multiple Oct2 isoforms are generated by alternative splicing.
Wirth T; Priess A; Annweiler A; Zwilling S; Oeler B
Nucleic Acids Res; 1991 Jan; 19(1):43-51. PubMed ID: 2011512
[TBL] [Abstract][Full Text] [Related]
10. Btk expression is controlled by Oct and BOB.1/OBF.1.
Brunner C; Wirth T
Nucleic Acids Res; 2006; 34(6):1807-15. PubMed ID: 16582106
[TBL] [Abstract][Full Text] [Related]
11. Expression patterns of the four nuclear factor I genes during mouse embryogenesis indicate a potential role in development.
Chaudhry AZ; Lyons GE; Gronostajski RM
Dev Dyn; 1997 Mar; 208(3):313-25. PubMed ID: 9056636
[TBL] [Abstract][Full Text] [Related]
12. rel/NF-kappa B nuclear complexes that bind kB sites in the murine c-rel promoter are required for constitutive c-rel transcription in B-cells.
Grumont RJ; Richardson IB; Gaff C; Gerondakis S
Cell Growth Differ; 1993 Sep; 4(9):731-43. PubMed ID: 8241021
[TBL] [Abstract][Full Text] [Related]
13. A B-cell coactivator of octamer-binding transcription factors.
Gstaiger M; Knoepfel L; Georgiev O; Schaffner W; Hovens CM
Nature; 1995 Jan; 373(6512):360-2. PubMed ID: 7779176
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the cysteine-rich secretory protein 3 gene as an early-transcribed gene with a putative role in the pathophysiology of Sjögren's syndrome.
Tapinos NI; Polihronis M; Thyphronitis G; Moutsopoulos HM
Arthritis Rheum; 2002 Jan; 46(1):215-22. PubMed ID: 11817594
[TBL] [Abstract][Full Text] [Related]
15. Cloning and expression of human B cell-specific transcription factor BACH2 mapped to chromosome 6q15.
Sasaki S; Ito E; Toki T; Maekawa T; Kanezaki R; Umenai T; Muto A; Nagai H; Kinoshita T; Yamamoto M; Inazawa J; Taketo MM; Nakahata T; Igarashi K; Yokoyama M
Oncogene; 2000 Aug; 19(33):3739-49. PubMed ID: 10949928
[TBL] [Abstract][Full Text] [Related]
16. The BOB.1 / OBF.1 co-activator is essential for octamer-dependent transcription in B cells.
Laumen H; Nielsen PJ; Wirth T
Eur J Immunol; 2000 Feb; 30(2):458-69. PubMed ID: 10671201
[TBL] [Abstract][Full Text] [Related]
17. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
Liebermann DA; Hoffman B
Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003
[TBL] [Abstract][Full Text] [Related]
18. A novel octamer regulatory element in the VH11 leader exon of B-1 cells.
Goodglick L; Felsher DW; Neshat MS; Braun J
J Immunol; 1995 May; 154(9):4546-56. PubMed ID: 7722308
[TBL] [Abstract][Full Text] [Related]
19. PU.1/Spi-1 is essential for the B cell-specific activity of the mouse CD72 promoter.
Ying H; Chang JF; Parnes JR
J Immunol; 1998 Mar; 160(5):2287-96. PubMed ID: 9498769
[TBL] [Abstract][Full Text] [Related]
20. IPEB transcription factor regulating the intracisternal A particle gene during F9 cell differentiation is expressed at sites of lymphoid development.
Kamat JP; Basu A; Satyamoorthy K; Xu MQ; Showe L; Howe CC
Mol Reprod Dev; 1995 May; 41(1):8-15. PubMed ID: 7619510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
